跳至主要内容
临床试验/PACTR202310892230317
PACTR202310892230317尚未招募4 期

Safe Blood for Kano: Cross-sectional and longitudinal population-based study on blood donor and transfusion recipient characteristics in Northern Nigeria

Institute of Transfusion Medicine University of Greifswald0 个研究点目标入组 50,000 人开始时间: 2023年9月16日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Day(s) 至 1 Month(s)(—)
性别
All

入选标准

  • All blood donors and transfusion recipients in 10 hospitals in the region of the city of Kano, Nigeria;
  • Fulfilling Nigerian criteria for blood donation (for blood donors);
  • Hemoglobin of >12.5g/dl and 13.5g/dl (females and males respectively),
  • Negative rapid screening test for Transfusion Transmitted Infections (TTIs).
  • All subjects in whom the treating physician defined an indication for blood transfusion will be enrolled.

排除标准

  • All subjects with exclusion criteria for blood donation according to the Nigerian regulations.
  • 1. Hemoglobin < 12.5g/dl and 13.5g/dl in females and males respectively
  • 2. Evidence for the presence of TTI, HIV, HBV, HCV, VLDR,
  • 3. Severe infection
  • 5. Body weight < 50 kg

研究者

发起方
Institute of Transfusion Medicine University of Greifswald

相似试验

Jini Na Project | 临床试验